← Eichor
Study identifier: NCT05071131 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effect of Inulin on Gut Microbiota and Gut Barrier in Chronic Kidney Disease

Condition: Chronic Kidney Disease 5D  ·  Sponsor: Charite University, Berlin, Germany

PhaseNA
Planned participants40
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

An adequate fiber intake is crucial for a well-balanced diet and reduces the risk of chronic diseases. However, nutritional recommendations for chronic kidney disease patients lead to an insufficient fiber intake with possible maladaptive effects on the gut microbiome. Therefore, we want to study the effects of a 35-day inulin supplementation on the gut microbiome, gut barrier function, bacterial metabolites and immune cell states in chronic kidney disease patients.

This description comes directly from the study's public registry record.

Talk to the study team

Victoria McParland, PhD  ·  +49 30 450 540 464  ·  victoria.mcparland@charite.de

Always discuss trial participation with your own doctor first.

Locations (1)

Experimental and Clinical Research CenterBerlin, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05071131